About Us
Improving people’s lives through human genetics is our Ultimate Goal.
G&life was established in 2009, in one of the most important science parks in Europe – AREA Science Park – in the only Strong Innovator Region of Italy recognized by European Innovation Scoreboard.
Now the company is part of Biovalley Investment Partners, a holding specialized in investments in innovative companies operating in the BioHighTech (BioMed, Biotech, BioICT) life sciences and medical markets.
Born from research, G&life has always had a serious and innovative approach to the solutions it proposes.
We are the only company in the world with a patented method, tested by a third party for 2 years on 200 people, with results presented at the international scientific conference “European Human Genetics Conference” in 2014.
We are among the first to consider both individual genetics and epigenetics in its solutions.
High Quality Innovative Solutions
Numbers Speak For Themselves
12+
Years of Experience
9+
Prizes and Awards
1
Patented Method
Founders
Prof. Paolo Gasparini, MD, PhD
Full Professor of Medical Genetics at the University of Trieste, Director of the Department of Advanced Diagnosis and Clinical Research and Director of the Medical Genetics service, at the IRCCS Burlo Garofolo Children’s Hospital of Trieste.
Winner of the Great Hippocrates Prize in 2011, thanks to his studies on the relationships between genome, dietary behavior and health implications.
He was director of the genetics division of the Sidra hospital (Doha, Qatar).
He has more than 300 publications in peer-reviewed international journals, with a total Impact Factor higher than 1900.
In 2020 he was appointed Expert in the “transfer of genomic therapy into clinical practice” by the Istituto Superiore di Sanità (National Institute of Health).
In 2021 he was appointed President of the Italian Society of Human Genetics (SIGU), the national reference structure for topics of scientific and health interest concerning Human Genetics in all its applicative aspects.
Ing. Francesco Menegoni, PhD
G&life CEO, Biomedical engineer, doctor of bioengineering.
He was biomedical researcher at the Politecnico di Milano and at the Italian Auxological Institute: in particular, the study of biomedical computer science and the biomechanics of human movement also in relation to obesity. In these fields he is the author of numerous international scientific publications.
In 2020 he was appointed National Expert by the Italian Ministry of Innovation and Digitization.
The multidisciplinary team includes Geneticists, Nutritionists, Pharmacists, Biologists and Engineers who have developed the products and services of G&life.
